“Backed by $15 million in Series A funding, Taiwanese life science firm Syncell is looking to drive commercialization of its spatial proteomics platform. Called Microscoop, the company’s technology lets users extract proteins from specific cellular regions of interest and measure them via methods like mass spectrometry, an approach that enables untargeted spatial proteomic analyses.”
Read the full story on GenomeWeb (requires subscription).
